Hints and tips:
...Banco Santander, BT Group, Centrica, CMC Markets, Co-operative Bank, CVS Group, Diageo, Enel, Hammerson, JCDecaux, L’Oréal, Leonardo, Nestlé, OMV, Orange, Relx, Rentokil Initial, Repsol, Royal Dutch Shell, Sanofi-Aventis...
...H1, Mastercard Q2, Merck & Co Q2, Nestlé H1, Nissan Motor Q1, Northrop Grumman Q2, OMV Q2, Orange H1, Panasonic Q1, Pfizer Q2, Relx H1, Rentokil Initial H1, Repsol Q2, Royal Dutch Shell Q2, Samsung Q2, Sanofi-Aventis...
..., monthly motor vehicle sales, payrolls and unemployment figures Results: Aon Q4, Bristol-Myers Squibb Q4, Carlsberg FY, Intesa Sanpaolo FY, Regeneron Pharmaceuticals Q4, Sanofi-Aventis Q4, Sumitomo Q3,...
...Q2 Mediobanca Q2 Merck & Co Q2 National Express H1 Nestle H1 Northrop Grumman Q2 Orange H1 Panasonic Q1 Pinterest Q1 Rentokil H1 Repsol Q2 Royal Dutch Shell Q2 Saint-Gobain H1 Samsung Q2 Sanofi-Aventis...
...Centerview, which launched just over a decade ago, has emerged as a rival to Lazard in the US and will immediately challenge it on its home turf....
...Big US tech companies spent nearly $5bn on healthcare acquisitions between 2012 and September 2018, says CB Insights....
...It has been a year that most US distressed hedge funds would love to forget....
...Verily products like Onduo, a joint venture with Sanofi to create a diabetes management platform, might move closer to Google Health....
...Large corporations, including Unilever, Akzo Nobel and Sanofi, are all looking to dispose of multibillion units in the coming months and are all likely targets for private equity....
...China is Pfizer’s third biggest market after the US and Japan....
...AkzoNobel has also put its specialty chemicals unit up for sale, and Sanofi is selling a drug unit. Both auctions have attracted interest from private equity....
...Sanofi, the French drugmaker, is seeking to sell its European generic drug business for about €3bn, drawing interest from a consortium formed by Cinven and Bain Capital....
...Last month, Sanofi the French pharmaceutical company said it would buy Bioverativ, a US biotech group focused on haemophilia treatments, for $11.6bn — a premium of about 64 per cent to where it was trading...
...After a spate of foreign takeovers of Indian drugmakers by companies such as Daiichi Sankyo, Sanofi-Aventis and Abbott Laboratories in the past decade, some policymakers demanded that pharmaceuticals be...
...Mr Miels started his pharmaceuticals career at AstraZeneca in 1995, leaving in 2000 for Sanofi-Aventis before joining Switzerland’s Roche in 2006, where he ran the company’s Asia business....
...While not seen in Germany before, Braas’s tactic has some similarities to that deployed by French drugmaker Aventis in 2004, in an attempt to avoid being acquired by Sanofi in a $60bn deal....
...Since last Thursday more than $55bn have been spent by large companies, including Abbott Laboratories, AbbVie and Sanofi to secure growth generating assets....
...Sanofi and Aventis merged to take on US pharma, but have not caught Pfizer. Nor have Glaxo and SmithKline Beecham....
...One of the latest signs of progress came in April 2016 when the World Health Organisation recommended that countries consider using Sanofi’s vaccine to combat dengue fever....
...Relypsa is on course to launch Veltassa by January 2016 with Sanofi its US marketing partner. (Vifor Fresenius Medical Care has the deal for marketing rights outside the US.)...
...Later he was with Aventis, another Franco-German drugmaker, in the US when it merged with France’s Sanofi. His experience of these deals was mostly negative. “Sanofi-Aventis didn’t work,” he says....
...Then, three months ago, the group sold its diabetes devices unit to Panasonic Healthcare, which is controlled by KKR, the US private equity group, for €1.02bn....
...The business has a relationship with many of the big regional pharmaceutical companies, as well as some multinationals including French drugmaker Sanofi-Aventis....
...The former chief executive of Sanofi was named on Tuesday as managing partner of US-based Gurnet Point Capital, part of the Bertarellis’ Waypoint Capital group....
...Mylan of the US and Lupin of India are among potential trade buyers to have been linked with one or both of the GSK and Sanofi businesses....
International Edition